HOME >> BIOLOGY >> NEWS
New mode of action discovered for tamoxifen

IOWA CITY, Iowa -- First used to treat breast cancer more than 30 years ago, tamoxifen now is one of the most widely used breast cancer therapies. University of Iowa researchers have discovered a new mode of action for tamoxifen, which could lead to better targeting of the therapy and possibly the development of new anti-cancer drugs.

In breast tissue, tamoxifen acts as an anti-estrogen, meaning that it blocks the action of the hormone estrogen. Normal breast cells grow in response to estrogen in a controlled fashion. However, in breast cancer, this cell growth is out of control. Treatment with the anti-estrogen tamoxifen inhibits the uncontrolled cell growth and keeps cancer in check.

In a new study, which appears in the Jan. 15 issue of Clinical Cancer Research, researchers based at the Holden Comprehensive Cancer Center at the UI have identified another way that tamoxifen can prevent cancerous growth. The study indicates that tamoxifen treatment causes the re-expression of a tumor suppressor gene known as maspin.

Maspin protein has been shown to inhibit tumor invasion and metastasis, and in normal breast cells, maspin protein is abundant. However, in breast cancer, maspin gene expression is diminished or lost and tumors can form and spread unchecked. Previous studies have shown that reintroducing maspin into breast cancer cells, which have lost the gene expression, causes cancers to be less invasive.

The UI study showed that treatment with tamoxifen turned maspin expression back on in breast cancer cells that had lost the gene expression. The study suggests that one of tamoxifen's beneficial effects is due to its ability to turn maspin expression back on. Moreover, the researchers also found similar results in tissue samples from breast cancer patients who had been treated with tamoxifen.

"Looking at the tumor samples we found up-regulation of maspin in these samples too. That was further confirmation of what we s
'"/>

Contact: Jennifer Brown
jennifer-l-brown@uiowa.edu
319-335-9917
University of Iowa
30-Jan-2004


Page: 1 2

Related biology news :

1. DNA lends scientists a hand, revealing new chemical reactions
2. Charting the future in prostate cancer care: A call to action
3. Defensive action by influenza viruses demonstrated by Hebrew university researcher
4. Long-term effects of carbon monoxide poisoning are an autoimmune reaction
5. Common call for action on European Research Council (ERC)
6. New technique helps scientists reveal interactions between genes and drugs
7. Rutgers cancer prevention expert calls for FDA action to reduce colon cancer and osteoporosis
8. Rutgers chemist uses NMR to elucidate protein-DNA interaction
9. Findings suggest need for new view of p53 cancer proteins interaction with DNA
10. A pregnant pause for unexpected interactions
11. Infusion of two peptides acts to accelerate appetite satisfaction

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2019)... ... August 15, 2019 , ... Deep Science Ventures ... Food and Agriculture practice, a new unit dedicated to building 100 companies over the ... raw materials and supply chains. , Deep Science Ventures was founded to create ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research ... EDT to learn about two common imaging methods in NAFLD/NASH to aid with early ... diffuse liver disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided ...
(Date:8/9/2019)... ... , ... With a demand in healthcare to lower unneeded emergency room visits ... centers (UCC) in the coming years, according to a new report on the industry ... Centers , is a detailed look at the current state of these healthcare outlets, ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 10, 2019 , ... ... and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local ... Group) and will educate viewers about how its technology facilitates laboratories to improve ...
(Date:6/11/2019)... Md. and ROANOKE, Va. (PRWEB) , ... June ... ... care optimized for microlearning engagement, and Carilion Clinic, a national leader in opioid ... the latest in virtual care. , Mytonomy recently deployed its virtual ...
(Date:6/11/2019)... N.C. (PRWEB) , ... June 11, 2019 , ... ... extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate ... cloning ability. In a test on mice, MSC-EVs also increased the cells’ ability ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
Breaking Biology Technology:
Cached News: